Science Current Events | Science News |

Faster, more efficient CRISPR editing in mice

May 27, 2016

University of California, Berkeley scientists have developed a quicker and more efficient method to alter the genes of mice with CRISPR-Cas9, simplifying a procedure growing in popularity because of the ease of using the new gene-editing tool.

While CRISPR-Cas9 has drawn worldwide attention because of its potential to correct simple hereditary diseases in humans, basic researchers are excited about its ability to help them understand the causes and develop treatments for more complex diseases, including cancer and dementia.

To do that, they need to knock out or modify specific genes in lab animals - in particular, mice - and see what goes awry. Today's gold standard for creating these "knockouts" or "knockins" is to edit the genes inside mouse embryonic stem cells, use these cells to create mosaic mice, and then crossbreed the mice to get a pure genetic strain. Because of CRISPR-Cas9's ability to precisely alter or replace genes, the editing is increasingly being done directly in the fertilized egg, or early embryo.

The new method, called CRISPR-EZ (CRISPR RNP electroporation of zygotes), makes genome editing in mouse embryos even easier.

"The key fundamental insights about the biological significance of a gene usually come from in vivo gene-editing studies, in which you generate mice with an altered gene," said lead researcher Lin He, a UC Berkeley associate professor of molecular and cell biology. "But it is a major committment to make a novel knockout with genome engineering. I think this technology could greatly reduce the technical barrier for this type of effort and will allow people to focus more on the science rather than be consumed by the process of genetically engineering mice."

The new method, described in this week's issue of the Journal of Biological Chemistry, gets around a time-consuming bottleneck in creating knockout mice: using microscopic needles to inject gene-editing molecules into a fertilized egg.

The UC Berkeley researchers found that a simple lab technique called electroporation works much better, allowing them to insert CRISPR-Cas9 gene-editing molecules into embryos with nearly 100 percent success. Electroporation uses a jolt of electricity to create holes in the embryos through which molecules can enter.

Using CRISPR-EZ in a pilot experiment, He's team successfully disrupted both copies of a target gene in 88 percent of the mice. The procedure generated a much greater number of edited mice compared to CRISPR microinjection, largely due to a significant improvement in embryo viability. CRISPR-EZ is a simple and cost-effective methodology, and can be performed on many embryos at once and takes only miliseconds, He said.

"In the not too distant past, it would cost at least $25,000 and take at least 6 months to make a knockout mouse," said Russell Vance, a UC Berkeley professor of molecular and cell biology and director of the Cancer Research Laboratory, where the transgenic mouse work was performed. "With CRISPR, and improvements such as CRISPR-EZ, the costs and time have both dropped at least 10-fold. These technical innovations make the mouse an even more powerful tool for modeling human diseases."

The UC Berkeley group is now working with several transgenic mouse facilities in hopes that they will adopt and improve this electroporation technique, which she suspects will also simplify the creation of other transgenic mammals.

Knockouts require IVF team

Creating transgenic mice requires a skilled in vitro fertilization team. Technicians use hormone injections to prepare the females for mating, after which they harvest the fertilized eggs and, before the eggs start to divide, inject them one at a time using a fine needle. Currently, technicians inject two RNA molecules - messenger RNA (mRNA), which codes for the Cas9 protein, and guide RNA, which provides the address for CRISPR-Cas9's target - and hope that the mRNA is properly translated into Cas9 protein and that the protein correctly combines with guide RNA.

The engineered embryos are implanted into a falsely pregnant mouse, where they gestate for about 20 days before birth. Given the inevitable embryo deaths during injection and the failure of the embryos to implant or go to term, the live-birth rate is low, He said.

"The actual percentage of live births from injected embryos is around 10 to 15 percent for most transgenic facilities, which is a problem with the procedure," she said. "Sometimes people collect more than 100 embryos just to generate one or two mice with desirable gene editing."

Electroporation appears to do less damage to the embryos than microinjection: between 30 and 50 percent of the embryos resulted in live births.

Apparently, too, inserting pre-assembled CRISPR-Cas9 molecules into the fertilized egg is a more effective way to edit genes than injecting two molecules - the mRNA and guide RNA - and hoping that they properly self-assemble. Of the live births, 88 percent of the mice had both copies of the target gene edited - a higher success rate than usual for transgenic procedures, He said.

For a more complex procedure - modifying a short DNA sequence within a gene - the method was successful 42 percent of the time in a pilot experiment.

"With such a high success rate, you can use this to test your guide RNAs very quickly," she said. "If your CRISPR-EZ doesn't work, it's not because of delivery; it's likely because your guide RNA design needs to be improved."

The high embryo viability and very high gene-editing efficiency mean researchers need to use fewer mice and can conduct several transgenic experiments simultaneously.

Accidental discovery

In her lab, He studies small bits of RNA called microRNA, which modify how DNA is transcribed and thus control important processes inside a cell. Some types of cancer have been linked to problems with miRNA.

Looking for a simpler way to create transgenic mice to study these regulatory processes, postdoctoral fellow Andrew Modzelewski tested electroporation to see if he could get eggs to more easily take up the Cas9 mRNA and the guide RNA. Despite other researchers' apparent success with mRNA, his initial attempts were unsuccessful. One evening, finding himself out of mRNA and not wanting to waste the prepared embryos, he borrowed CRISPR-Cas9 protein from a neighboring lab, assembled RNP complexes and electoporated them instead.

"It has worked like magic ever since," He said. "You would never think that this would work, because Cas9 is a gigantic molecule. I was surprised that such a huge protein could be electroporated efficiently."

While most universities have transgenic labs where microinjections are performed, electroporation simplifies the procedure enough that individual labs might eventually do it themselves, she predicted.


Graduate student Sean Chen and postdoctoral fellow Andrew Modzelewski spearheaded this study, Other co-authors of the paper are undergraduate Benjamin Lee and Angus Yiu-Fai Lee, director of the Gene Targeting Facility in UC Berkeley's Cancer Research Laboratory. This work has also benefited from input from Jacob Corn, Mark DeWitt and Jennifer Doudna from UC Berkeley's Innovative Genomics Initiative.

This work was supported by the National Cancer Institute (R01 CA139067) and National Institute of General Medical Science (RO1 1R01GM114414) of the National Institutes of Health.

University of California - Berkeley

Related CRISPR-Cas9 Current Events and CRISPR-Cas9 News Articles

Automating DNA origami opens door to many new uses
Researchers can build complex, nanometer-scale structures of almost any shape and form, using strands of DNA. But these particles must be designed by hand, in a complex and laborious process.

A guide to CRISPR gene activation
The CRISPR-Cas9 system has come to be known as the quintessential tool that allows researchers to edit the DNA sequences of many organisms and cell types.

Two-pronged attack on chemotherapy-resistant leukemia cells
Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer in Switzerland. Despite intensive chemotherapy, one fifth of the patients suffer a relapse, which usually goes hand in hand with a poor prognosis.

Update on advances in gene therapy From National Center for Advancing Translational Sciences
New initiatives by the National Center for Advancing Translational Sciences (NCATS) to use gene therapy approaches to treat rare diseases and especially promising aspects of gene transfer and gene editing technology, such as adeno-associated viral (AAV) vectors and CRISPR-Cas9 are highlighted in an editorial published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Virginia Tech researchers suggest gene drive strategy to combat harmful virus spread
With the outbreak of viruses like Zika, chikungunya, and dengue on the rise, public health officials are desperate to stop transmission.

Stem cell gene therapy could be key to treating Duchenne muscular dystrophy
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Center for Duchenne Muscular Dystrophy at UCLA have developed a new approach that could eventually be used to treat Duchenne muscular dystrophy.

New tool for efficiently validating the accuracy of CRISPR-Cas9 reactions
CRISPR-Cas9's popularity continues to grow ever since its first use in genome editing in January, 2013. What makes CRISPR-Cas9 so remarkable is its astonishing efficiency and availability; relatively speaking, it is easy to use.

CRISPR/Cas9 therapeutic for tyrosinemai type I delivered to mice
University of Massachusetts Medical School researchers have found a way to more efficiently delivery a CRISPR/Cas9 therapeutic to adult mice with the metabolic disease Tyrosinemia type I that may also prove to be safer for use in humans.

Advance improves cutting and pasting with CRISPR-Cas9 gene editing
University of California, Berkeley, researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.

Gene-editing technique successfully stops progression of Duchenne muscular dystrophy
Using a new gene-editing technique, a team of scientists from UT Southwestern Medical Center stopped progression of Duchenne muscular dystrophy (DMD) in young mice.
More CRISPR-Cas9 Current Events and CRISPR-Cas9 News Articles

Modern Prometheus: Editing the Human Genome with Crispr-Cas9

Modern Prometheus: Editing the Human Genome with Crispr-Cas9
by Jim Kozubek (Author)

Would you change your genes if you could? As we confront the 'industrial revolution of the genome', the recent discoveries of Crispr-Cas9 technologies are offering, for the first time, cheap and effective methods for editing the human genome. This opens up startling new opportunities as well as significant ethical uncertainty. Tracing events across a fifty-year period, from the first gene splicing techniques to the present day, this is the story of gene editing - the science, the impact and the potential. Kozubek weaves together the fascinating stories of many of the scientists involved in the development of gene editing technology. Along the way, he demystifies how the technology really works and provides vivid and thought-provoking reflections on the continuing ethical debate....

A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution

A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution
by Jennifer A. Doudna (Author), Samuel H. Sternberg (Author)

A trailblazing biologist grapples with her role in the biggest scientific discovery of our era: a cheap, easy way of rewriting genetic code, with nearly limitless promise and peril.

Not since the atomic bomb has a technology so alarmed its inventors that they warned the world about its use. Not, that is, until the spring of 2015, when biologist Jennifer Doudna called for a worldwide moratorium on the use of the new gene-editing tool CRISPR—a revolutionary new technology that she helped create—to make heritable changes in human embryos. The cheapest, simplest, most effective way of manipulating DNA ever known, CRISPR may well give us the cure to HIV, genetic diseases, and some cancers, and will help address the world’s hunger crisis. Yet even the tiniest changes to DNA...

Genome editing with the CRISPR Cas9 system

Genome editing with the CRISPR Cas9 system
by Paris Roidos (Author)

Genome engineering is just about its dawn of golden age. New and exciting tools are arising and piling up to its arsenal. After TALENs and Zing-finger a new and lot worthy tool is coming to add up. The newest addition is the CRISPR system. A system that firstly discovered at the Streptococcus thermophilus and its natural role is the sequence-specific adaptive immunity against foreign DNA in bacteria. In the present report, CRISPR Cas9, type II system, is used in an attempt to knock out the HPRT1 gene expressed in lymphocytes as a proof of concept. HAT medium in combination with Thioguanine is used as a selection medium enabling a quick and simple read-out screening method. To verify that a successful editing event took place in the mammalian cells, a detection DNA cleavage kit is used in...

Evolving Ourselves: Redesigning the Future of Humanity--One Gene at a Time

Evolving Ourselves: Redesigning the Future of Humanity--One Gene at a Time
by Juan Enriquez (Author), Steve Gullans (Author)

An eye-opening, mind-bending exploration of how mankind is reshaping its genetic future, based on the viral TED Talk series “Will Our Kids Be a Different Species?” and “The Next Species of Human.”

Are you willing to engineer the DNA of your unborn children and grand-children to be healthier? Better looking? More intelligent? Why are rates of autism, asthma, and allergies exploding at an unprecedented pace? Why are humans living longer and having far fewer kids?

Futurist Juan Enriquez and scientist Steve Gullans conduct a sweeping tour of how humans are changing the course of evolution for all species—sometimes intentionally, sometimes not. For example:

• What if life forms are limited only by the bounds of our imagination? Are designer babies and pets,...

CRISPR GERMLINE ALTERATION : De-Extinction Research ,CRISPR/cas9, Designer babies and Gene editing (ZFN, TALEN,Life extension of Reverse aging ): IMPACT ON HUMAN CIVILIZATION

CRISPR GERMLINE ALTERATION : De-Extinction Research ,CRISPR/cas9, Designer babies and Gene editing (ZFN, TALEN,Life extension of Reverse aging ): IMPACT ON HUMAN CIVILIZATION


At the very depths of an organism, we have the life.The hitherto unbreakable mechanism of gene interaction has been snipped apart by the revolutionary technique known as CRISPR. In this book, "CRISPR Germline Alteration and Impact on Human Civilization" ,we will uncover the emerging field of genetic modification and see changes that will fashion our lifestyle in the next few years. Humans perform activity through the energy functions performed within the cells. Through simple changes, we can increase the flow of energy, just by augmenting the work function of one particular gene. We are caught up in the awesomeness of the moment, just as our fathers were, when they first witnessed the fantastic power of the steam engine. And believe me, CRISPR is very powerful indeed....

CRISPR-Cas: A Laboratory Manual

CRISPR-Cas: A Laboratory Manual
by Jennifer Doudna (Editor), Prashant Mali (Editor)

The development of CRISPR-Cas technology is revolutionizing biology. Based on machinery bacteria use to target foreign nucleic acids, these powerful techniques allow investigators to edit nucleic acids and modulate gene expression more rapidly and accurately than ever before.

Featuring contributions from leading figures in the CRISPR-Cas field, this laboratory manual presents a state-of-the-art guide to the technology. It includes step-by-step protocols for applying CRISPR-Cas-based techniques in various systems, including yeast, zebrafish, Drosophila, mice, and cultured cells (e.g., human pluripotent stem cells). The contributors cover web-based tools and approaches for designing guide RNAs that precisely target genes of interest, methods for preparing and delivering CRISPR-Cas...

''A Glimpse of current/recent CRISPR – Cas9 Research News..'': Should human embryos be Genetically modified, by using CRISPR – Cas9?

''A Glimpse of current/recent CRISPR – Cas9 Research News..'': Should human embryos be Genetically modified, by using CRISPR – Cas9?

In fact, for many years now, scientists have been experimenting on gene editing techniques in order to find the best tool to alter the DNA of human beings. It is through this search that animal and plant genes were altered by scientists.
With the discovery of CRISPR, it allows scientists to edit human genes with unprecedented precision, efficiency, and flexibility.
So far, scientists claim to have successfully used CRISPR to create monkeys with targeted mutations to prevent HIV infection in human cells.
The technique could permanently remove harmful mutations which lead to inherited diseases like Huntingdon’s, cystic fibrosis and haemophilia, critics say it could have unexpected side effects any may damage healthy strands of DNA. Critics warn that allowing...

CRISPR: Methods and Protocols (Methods in Molecular Biology)

CRISPR: Methods and Protocols (Methods in Molecular Biology)
by Magnus Lundgren (Editor), Emmanuelle Charpentier (Editor), Peter C. Fineran (Editor)

This volume presents a list of cutting-edge protocols for the study of CRISPR-Cas defense systems and their applications at the genomic, genetic, biochemical and structural levels. CRISPR: Methods and Protocols guides readers through techniques that have been developed specifically for the analysis of CRISPR-Cas and techniques adapted from standard protocols of DNA, RNA and protein biology. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.Authoritative and cutting-edge, CRISPR: Methods and Protocols provides a broad list of tools and...

Targeted Genome Editing Using Site-Specific Nucleases: ZFNs, TALENs, and the CRISPR/Cas9 System

Targeted Genome Editing Using Site-Specific Nucleases: ZFNs, TALENs, and the CRISPR/Cas9 System
by Takashi Yamamoto (Editor)

This book serves as an introduction to targeted genome editing, beginning with the background of this rapidly developing field and methods for generation of engineered nucleases. Applications of genome editing tools are then described in detail, in iPS cells and diverse organisms such as mice, rats, marine invertebrates, fish, frogs, and plants. Tools that are mentioned include zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas9, all of which have received much attention in recent years as breakthrough technologies. Genome editing with engineered nucleases allows us to precisely change the target genome of living cells and is a powerful way to control functional genes. It is feasible in almost all organisms ranging from bacteria to...

The Use of CRISPR/cas9, ZFNs, TALENs in Generating Site-Specific Genome Alterations, Volume 546 (Methods in Enzymology)

The Use of CRISPR/cas9, ZFNs, TALENs in Generating Site-Specific Genome Alterations, Volume 546 (Methods in Enzymology)
by Jennifer A. Doudna (Editor), Erik J. Sontheimer (Editor)

This new volume of Methods in Enzymology continues the legacy of this premier serial with quality chapters authored by leaders in the field. This volume covers recent research and methods development for changing the DNA sequence within the genomes of cells and organisms. Focusing on enzymes that generate double-strand breaks in DNA, the chapters describe use of molecular tools to introduce or delete genetic information at specific sites in the genomes of animal, plant and bacterial cells.Continues the legacy of this premier serial with quality chapters authored by leaders in the fieldCovers research methods in biomineralization scienceContains sections on such topics as genome editing, genome engineering, CRISPR, Cas9, TALEN and zinc finger...

© 2017